Real-World Long-Term Efficacy of Cladribine Tablets in a Tertiary Referral Center

被引:0
|
作者
Skuljec, Jelena [1 ]
Kleinschnitz, Christoph [1 ]
Pul, Refik [1 ]
机构
[1] Univ Med Essen, Neurol, Essen, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P863/2260
引用
收藏
页码:669 / 670
页数:2
相关论文
共 50 条
  • [1] Sustained efficacy of cladribine tablets in the longer term: A real-world, multicentre study
    Brownlee, Wallace
    He, Anna
    Adib-Samii, Poneh
    Mohamed, Bader
    Schmierer, Klaus
    Bezzina, Lindsey
    Brex, Peter
    Clark, Deborah
    Falah, Yasser
    Raftopoulos, Rhian
    Silber, Eli
    Pipis, Menelaos
    Porter, Marie-Claire
    Williams, Victoria
    Edwards, Angharad
    Sanvito, Lara
    White, Sarah
    Athukoralage, Kasun
    Nasir, Moneeb
    Mattoscio, Miriam
    De Angelis, Floriana
    Wilson, Heather
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 647 - 648
  • [2] Early Real-World Safety, Tolerability, and Efficacy of Cladribine Tablets: A Single Center Experience
    Bain, Julie
    Jones, Ashley
    Overholt, Sarah
    Guenette, Melanie
    Selchen, Daniel
    Oh, Jiwon
    NEUROLOGY, 2020, 94 (15)
  • [3] Early real-world safety, tolerability, and efficacy of cladribine tablets: a single center experience
    Bain, J.
    Oh, J.
    Jones, A.
    Selchen, D.
    Overholt, S.
    Guenette, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 274 - 274
  • [4] Long-term Real-world Safety and Efficacy of Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE Experience
    Yamout, Bassem I.
    Shatila, Ahmad
    Inshasi, Jihad
    Hassan, Ali Mohammed Ali
    Szolics, Mikolas
    Hassan, Ahmed
    Farw, Ahmed
    Ismail, Ghida
    Zeineddine, Maya
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 379 - 379
  • [5] Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
    Oreja-Guevara, Celia
    Brownlee, Wallace
    Celius, Elisabeth G.
    Centonze, Diego
    Giovannoni, Gavin
    Hodgkinson, Suzanne
    Kleinschnitz, Christoph
    Kubala Havrdova, Eva
    Magyari, Melinda
    Selchen, Daniel
    Vermersch, Patrick
    Wiendl, Heinz
    Van Wijmeersch, Bart
    Salloukh, Hashem
    Yamout, Bassem
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 69
  • [6] Long-term, real-world efficacy of infliximab for psoriasis
    Mercieca, L.
    Warren, R. B.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E301 - E301
  • [7] Long-term evaluation of the efficacy of digital dermatoscopy monitoring at a tertiary referral center
    Rinner, Christoph
    Tschandl, Philipp
    Sinz, Christoph
    Kittler, Harald
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 (05): : 517 - 523
  • [8] Real-world Experience with Cladribine Tablets in the MSBase Registry
    Butzkueven, Helmut
    Spelman, Timothy
    Hodgkinson, Suzanne
    Kalincik, Tomas
    Buzzard, Katherine
    Skabina, Olga
    Madueno, Sara Eichau
    Ayuso, Guillermo Izquierdo
    Van der Walt, Anneke
    Grand-Maison, Francois
    Butler, Ernest
    Prevost, Julie
    McCombe, Pamela
    Oh, Jiwon
    Macdonell, Richard
    Lechner-Scott, Jeannette
    Van Pesch, Vincent
    Duquette, Pierre
    Prat, Alexandre
    Girard, Marc
    Kermode, Allan
    Fabris, Jessica
    NEUROLOGY, 2021, 96 (15)
  • [9] Real-world experience with cladribine tablets in the msbase registry
    Butzkueven, H.
    Spelman, T.
    Hodgkinson, S.
    Kalincik, T.
    Buzzard, K.
    Skibina, O.
    Eichau Madueno, S.
    Izquierdo, G.
    Van der Walt, A.
    Grand-Maison, F.
    Butler, E.
    Prevost, J.
    Mccombe, P.
    Oh, J.
    Macdonell, R.
    Lechner-Scott, J.
    Van Pesch, V.
    Duquette, P.
    Prat, A.
    Girard, M.
    Kermode, A.
    Fabris, J.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 549 - 549
  • [10] Real-world experience switching from high-efficacy infusions to cladribine tablets
    Negroski, D.
    Sellers, D.
    Khiabani, A.
    Khiabani, D.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 844 - 844